Niove E. Jordanides

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

Mhairi Copland, Ashley Hamilton, Lucy J. Elrick et al. · Blood · 2006 · 631 citations · Full text

Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells

Heather G. Jørgensen, Elaine Allan, Niove E. Jordanides et al. · Blood · 2007 · 302 citations · Full text

Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate

Niove E. Jordanides, Heather G. Jørgensen, Tessa L. Holyoake et al. · Blood · 2006 · 158 citations · Full text

Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters

Andrea Davies, Niove E. Jordanides, Athina Giannoudis et al. · Leukemia · 2009 · 101 citations

Nilotinib Concentration, Hematological Malignancy, Oncology +10

A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients

Niove E. Jordanides, Elaine Allan, Lorna McLintock et al. · Bone Marrow Transplantation · 2005 · 100 citations

Early Diagnosis, Diagnostic Mycology, Antifungal Agent +6